Ashton Thomas Private Wealth LLC Acquires 33 Shares of Axon Enterprise, Inc $AXON

Ashton Thomas Private Wealth LLC lifted its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 1.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,927 shares of the biotechnology company’s stock after purchasing an additional 33 shares during the period. Ashton Thomas Private Wealth LLC’s holdings in Axon Enterprise were worth $1,595,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. TCI Wealth Advisors Inc. bought a new position in shares of Axon Enterprise in the second quarter worth about $214,000. Duncker Streett & Co. Inc. increased its stake in shares of Axon Enterprise by 3.2% in the second quarter. Duncker Streett & Co. Inc. now owns 14,501 shares of the biotechnology company’s stock worth $12,006,000 after purchasing an additional 448 shares during the period. Quotient Wealth Partners LLC bought a new position in shares of Axon Enterprise in the first quarter worth about $438,000. GAMMA Investing LLC increased its stake in shares of Axon Enterprise by 11.8% in the first quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company’s stock worth $765,000 after purchasing an additional 154 shares during the period. Finally, DAVENPORT & Co LLC increased its stake in shares of Axon Enterprise by 5.1% in the first quarter. DAVENPORT & Co LLC now owns 940 shares of the biotechnology company’s stock worth $494,000 after purchasing an additional 46 shares during the period. 79.08% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. Bank of America lifted their price objective on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. JMP Securities restated a “market outperform” rating and set a $825.00 price target on shares of Axon Enterprise in a research note on Monday, September 29th. Northland Securities set a $800.00 price target on Axon Enterprise in a research note on Tuesday, August 5th. Piper Sandler assumed coverage on Axon Enterprise in a research note on Tuesday, September 23rd. They set an “overweight” rating and a $893.00 price target on the stock. Finally, Wolfe Research assumed coverage on Axon Enterprise in a research note on Monday, July 7th. They set an “outperform” rating on the stock. Fourteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus target price of $841.64.

Axon Enterprise Stock Up 0.8%

NASDAQ AXON opened at $755.00 on Wednesday. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The stock’s 50 day moving average is $732.26 and its two-hundred day moving average is $729.18. The company has a market capitalization of $59.27 billion, a price-to-earnings ratio of 186.42, a PEG ratio of 29.09 and a beta of 1.41. Axon Enterprise, Inc has a 1-year low of $422.38 and a 1-year high of $885.91.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. The company had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The company’s quarterly revenue was up 32.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Equities analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, August 11th. The stock was sold at an average price of $831.29, for a total value of $8,312,900.00. Following the transaction, the chief executive officer directly owned 3,053,982 shares of the company’s stock, valued at $2,538,744,696.78. The trade was a 0.33% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Joshua Isner sold 15,919 shares of the business’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the completion of the transaction, the president directly owned 238,379 shares in the company, valued at $177,892,712.54. The trade was a 6.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 59,932 shares of company stock worth $45,115,616 over the last ninety days. 5.70% of the stock is owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.